These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 21529896)

  • 41. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of anti-β2glycoprotein I IgA antibodies to the diagnosis of anti-phospholipid syndrome: potential interest of target domains to discriminate thrombotic and non-thrombotic patients.
    Despierres L; Beziane A; Kaplanski G; Granel B; Serratrice J; Cohen W; Bretelle F; Rossi P; Morange PE; Weiller PJ; Robert Harlé J; Bongrand P; Bardin N
    Rheumatology (Oxford); 2014 Jul; 53(7):1215-8. PubMed ID: 24599915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms.
    Chayoua W; Kelchtermans H; Moore GW; Gris JC; Musial J; Wahl D; Zuily S; Gianniello F; Fontana P; Remijn J; Urbanus RT; de Laat B; Devreese KMJ
    Thromb Haemost; 2019 May; 119(5):797-806. PubMed ID: 30822809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
    Sebastiani GD; Galeazzi M; Tincani A; Piette JC; Font J; Allegri F; Mathieu A; Smolen J; de Ramon Garrido E; Fernandez-Nebro A; Jedryka-Goral A; Papasteriades C; Morozzi G; Bellisai F; De Pitá O; Marcolongo R
    Scand J Rheumatol; 1999; 28(6):344-51. PubMed ID: 10665739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I--Anticardiolipin and anti-β2-glycoprotein I antibodies.
    Favaloro EJ; Wheatland L; Jovanovich S; Roberts-Thomson P; Wong RC
    Semin Thromb Hemost; 2012 Jun; 38(4):390-403. PubMed ID: 22570184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
    Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
    J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
    Vikerfors A; Johansson AB; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Nordmark G; Sturfelt G; Bengtsson A; Rönnblom L; Gunnarsson I; Elvin K; Svenungsson E
    Rheumatology (Oxford); 2013 Mar; 52(3):501-9. PubMed ID: 23159889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy.
    Montaruli B; De Luna E; Mengozzi G; Molinari F; Napolitano E; Napoli P; Nicolo C; Romito A; Stella S; Bazzan M; Bertero MT; Carignola R; Marchese C
    Lupus; 2012 Jun; 21(7):799-801. PubMed ID: 22635238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
    Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
    Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.